OBTAIN A: Outcome Benefits of Tranexamic Acid in Hip Arthroplasty. A Randomized Double-Blinded Controlled Trial

Journal of Arthroplasty

Volumn 32, Issue 5, 2017, Pages 1516-1519

  Fraval, Andrew ^a   Effeney, Peter ^b   Fiddelaers, Lena ^b   Smith, Belinda ^b   Towell, Ben ^b   Tran, Phong ^a,b  

^a WESTERN HEALTH   (Australia)

^b St Vincents Institute   (Australia)

Author keywords

anterior approach; blood loss; post operative outcomes; total hip arthroplasty; tranexamic acid

Indexed keywords

PLACEBO; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

10 METER WALK TEST; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HIP ARTHROPLASTY; HIP OSTEOARTHRITIS; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; PATIENT MOBILITY; PERIOPERATIVE PERIOD; POSTOPERATIVE PAIN; RANDOMIZED CONTROLLED TRIAL; SWELLING; THIGH SWELLING; TIMED UP AND GO TEST; VISUAL ANALOG SCALE; WALK TEST; DEVICES; HIP REPLACEMENT; MIDDLE AGED; PAIN MEASUREMENT; POSTOPERATIVE PERIOD; PROCEDURES; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PAIN MEASUREMENT; POSTOPERATIVE PERIOD; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 85009799751     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2016.11.045     Document Type: Article

References (21)

1. 1 Sukeik, M., Alshryda, S., Haddad, F.S., et al. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br, 93(1), 2011, 39.
2. 2 Dunn, C.J., Goa, K.L., Tranexamic acid: a review of its use in surgery and other indications. Drugs, 57(6), 1999, 1005.
3. 3 Henry, D., Carless, P., Moxey, A., et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev(1), 2011, CD001886.
4. 4 Ido, K., Neo, M., Asada, Y., et al. Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties. Arch Orthop Trauma Surg, 120, 2000, 518.
5. 5 Benoni, G., Fredin, H., Knebel, R., et al. Blood conservation with tranexamic acid in total hip arthroplasty: a randomized, double-blind study in 40 primary operations. Acta Orthop Scand, 72, 2001, 442.
6. 6 Husted, H., Blønd, L., Sonne-Holm, S., et al. Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplasty: a prospective randomized double-blind study in 40 patients. Acta Orthop Scand, 74, 2003, 665.
7. 7 Lemay, E., Guay, J., Côté, C., et al. Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement. Can J Anaesth, 51, 2004, 31.
8. 8 Yamasaki, S., Masuhara, K., Fuji, T., Tranexamic acid reduces blood loss after cementless total hip arthroplasty-prospective randomized study in 40 cases. Int Orthop, 28, 2004, 69.
9. 9 Johansson, T., Pettersson, L.G., Lisander, B., Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients. Acta Orthop, 76, 2005, 314.
10. 10 Niskanen, R.O., Korkala, O.L., Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis. Acta Orthop, 76, 2005, 829.
11. 11 Singh, J., Ballal, M.S., Mitchell, P., et al. Effects of tranexamic acid on blood loss during total hip arthroplasty. J Orthop Surg (Hong Kong), 18(3), 2010, 282.
12. 12 Bremer, A.K., Kalberer, F., Pfirrmann, C.W., et al. Soft-tissue changes in hip abductor muscles and tendons after total hip replacement: comparison between the direct anterior and the transgluteal approaches. J Bone Joint Surg Br, 93(7), 2011, 886.
13. 13 Bergin, P.F., Doppelt, J.D., Kephart, C.J., Comparison of minimally invasive direct anterior versus posterior total hip arthroplasty based on inflammation and muscle damage markers. J Bone Joint Surg Am, 93(15), 2011, 1392.
14. 14 Barrett, W.P., Turner, S.E., Leopold, J.P., Prospective randomized study of direct anterior vs postero-lateral approach for total hip arthroplasty. J Arthroplasty, 28(9), 2013, 1634.
15. 15 Imai, N., Dohmae, Y., Suda, K., et al. Tranexamic acid for reduction of blood loss during total hip arthroplasty. J Arthroplasty, 27(10), 2012, 1838.
16. 16 Stranden, E., A comparison between surface measurements and water displacement volumetry for the quantification of leg edema. J Oslo City Hosp, 31, 1981, 153.
17. 17 Gordon, D.B., Stevenson, K.K., Griffie, J., et al. Opioid equianalgesic calculations. J Palliat Med, 2(2), 1999, 209.
18. 18 Gross, J.B., Estimating allowable blood loss: corrected for dilution. Anesthesiology, 58, 1983, 277.
19. 19 Nadler, S.B., Hidalgo, J.U., Bloch, T., Prediction of blood volume in normal human adults. Surgery, 51, 1962, 224.
20. 20 Benoni, G., Lethagen, S., Nilsson, P., et al. Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty. Acta Orthop Scand, 71, 2000, 250.
21. 21 Garneti, N., Field, J., Bone bleeding during total hip arthroplasty after administration of tranexamic acid. J Arthroplasty, 19, 2004, 488.